[1]郭盼 刘晓琳 慕军平.血清miR-29联合LncRNA TUG1与ADMA对缺血性脑卒中的鉴别诊断价值[J].卒中与神经疾病杂志,2019,26(03):277-281.[doi:10.3969/j.issn.1007-0478.2019.03.005]
 Guo Pan,Liu Xiaolin,Mu Junping.The differential diagnosis value of serum miR-29 combined with lncRNA TUG1 and ADMA in ischemic stroke[J].Stroke and Nervous Diseases,2019,26(03):277-281.[doi:10.3969/j.issn.1007-0478.2019.03.005]
点击复制

血清miR-29联合LncRNA TUG1与ADMA对缺血性脑卒中的鉴别诊断价值()
分享到:

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第26卷
期数:
2019年03期
页码:
277-281
栏目:
论 著
出版日期:
2019-06-25

文章信息/Info

Title:
The differential diagnosis value of serum miR-29 combined with lncRNA TUG1 and ADMA in ischemic stroke
文章编号:
1007-0478(2019)03-0277-05
作者:
郭盼 刘晓琳 慕军平
712000 陕西省咸阳市延安大学咸阳医院检验科[郭盼 刘晓琳 慕军平(通信作者)]
Author(s):
Guo Pan Liu Xiaolin Mu Junping
Department of Laboratory, Xianyang Hospital, Yan'an University, Xianyang Shanxi 712000
关键词:
缺血性脑卒中 微小RNA 长链非编码RNA 非对称二甲基精氨酸
Keywords:
Ischemic stroke MicroRNA Long non-coding RNA Asymmetric dimethylarginine
分类号:
R743.3
DOI:
10.3969/j.issn.1007-0478.2019.03.005
文献标志码:
A
摘要:
目的 探讨血清微小RNA-29(miR-29)联合长链非编码RNA(lncRNA)TUG1及非对称二甲基精氨酸(ADMA)对缺血性脑卒中的鉴别诊断价值。方法 收集2017年6月-2018年7月本院确诊的缺血性脑卒中患者110例,选取出血性脑卒中患者80例,同期纳入本院的体检健康者100例; 采用实时荧光定量PCR(RT-PCR)法检测血清miR-29和LncRNA TUG1表达水平; 采用酶联免疫吸附法(ELISA)检测血清ADMA水平。结果 与出血性脑卒中组miR-29(60.7±4.3)-log,LncRNA TUG1(16.4±1.4)-log,ADMA(6.3±0.7)mIU/mL和健康对照组miR-29(62.3±4.8)-log; LncRNA TUG1(15.9±1.3)-log; ADMA(6.4±0.6)mIU/mL比较,缺血性脑卒中组血清LncRNA TUG1(43.5±3.5)-log和ADMA(11.4±1.4)mIU/mL水平显著升高,而血清miR-29(31.4±2.1)-log水平显著降低(P<0.05),而出血性脑卒中组和健康对照组血清miR-29、LncRNA TUG1及ADMA水平无明显差异(P>0.05)。Spearman相关性分析显示,血清LncRNA TUG1及ADMA水平与NIHSS评分(LncRNA TUG1:r=0.538,P=0.002; ADMA:r=0.566,P=0.001)呈正相关,而血清miR-29水平与NIHSS评分(miR-29:r=-0.545,P=0.001)呈负相关。血清miR-29、LncRNA TUG1及ADMA区分缺血性脑卒中与非缺血性脑卒中(出血性脑卒中和健康对照者)的AUC分别为0.863(95%CI=0.800~0.944,P<0.001)、0.912(95%CI=0.833~0.977,P<0.001)和0.764(95%CI=0.688~0.887,P<0.001); 敏感度及特异度分别为85.3%/82.1%、94.2%/73.5%和76.8%/81.2%; 对应的临界值分别为48.6-log、33.2-log和9.5 mIU/mL。当联合血清miR-29、LncRNA TUG1及ADMA时区分缺血性脑卒中与非缺血性脑卒中的AUC为0.945(95%CI=0.932~0.998,P<0.001),敏感度为83.8%,特异度为97.3%。结论 联合血清miR-29、LncRNA TUG1及ADMA对缺血性脑卒中具有潜在的鉴别诊断价值。
Abstract:
ObjectiveTo explore the differential diagnosis value of serum microRNA-29(miR-29)combined with long non-coding RNA(lncRNA)TUG1 and asymmetric dimethylarginine(ADMA)in ischemic stroke.Methods 110 patients with ischemic stroke diagnosed in our hospital from June 2017 to July 2018 were collected. 80 patients with hemorrhagic stroke were selected, and 100 healthy people were included in our hospital during the same period. Real-time PCR(RT-PCR)was used to detect the expression levels of serum miR-29 and LncRNA TUG1, and enzyme-linked immunosorbent assay(ELISA)was used to detect the level of serum ADMA.Results Compared with hemorrhagic stroke[miR-29:(60.7±4.3)-log, LncRNA TUG1:(16.4±1.4)-log, ADMA:(6.3±0.7)mIU/mL]and healthy controls(miR-29:(62.3±4.8)-log, LncRNA TUG1:(15.9±1.3)-log, ADMA:(6.4±0.6)mIU/mL], serum LncRNA TUG1(43.5±3.5)-log and ADMA(11.4±1.4)mIU/mL levels in patients with ischemic stroke were significantly increased(P<0.05), and the level of serum miR-29(31.4±2.1(-log))was significantly decreased(P<0.05). The levels of serum miR-29, LncRNA TUG1 and ADMA were not significantly different between hemorrhagic stroke and healthy controls(P>0.05). Spearman correlation analysis showed that serum levels of LncRNA TUG1 and ADMA were positively correlated with NIHSS score(LncRNA TUG1:r=0.538, P=0.002; ADMA:r=0.566, P=0.001), while serum level of miR-29 was negatively correlated with NIHSS score(mir-29:r=-0.545,P=0.001). The AUC of serum miR-29, LncRNA TUG1 and ADMA for ischemic stroke and non-ischemic stroke(hemorrhagic stroke and healthy controls)were 0.863(95% CI=0.800~0.944, P<0.001), 0.912(95% CI=0.833~0.977, P<0.001)and 0.764(95% CI=0.688~0.887, P<0.001); sensitivity and specificity were 85.3%/82.1%, 94.2%/73.5% and 76.8%/81.2%. The corresponding critical values were 48.6(-log), 33.2(-log)and 9.5 mIU/mL. When combined with serum miR-29, LncRNA TUG1 and ADMA, the AUC of ischemic stroke and non-ischemic stroke was 0.945(95%CI=0.932~0.998, P<0.001), and the sensitivity was 83.8%, the specificity was 97.3%.Conclusion Combined serum miR-29, LncRNA TUG1 and ADMA had potential diagnostic value in ischemic stroke.

参考文献/References:

[1] Young LH, Viscoli CM, Schwartz GG, et al. Heart failure after ischemic stroke or transient ischemic attack in Insulin-Resistant patients without diabetes mellitus treated with pioglitazone[J]. Circulation, 2018, 138(12):1210-1220.
[2] 任占云,汤武装,樊垚,等.超敏C-反应蛋白与缺血性脑卒中发病的前瞻性队列研究[J].中华疾病控制杂志,2018,22(1):29-32, 51.
[3] Kim AS, Cahill E, Cheng NT. Global stroke belt:geographic variation in stroke burden worldwide[J]. Stroke, 2015, 46(12):3564-3570.
[4] Kataoka T, Hotta Y, Maeda Y, et al. Testosterone deficiency causes endothelial dysfunction via elevation of asymmetric dimethylarginine and oxidative stress in castrated rats[J]. Journal of Sexual Medicine, 2017, 14(12):1540-1548.
[5] Kwah LK, Diong J. National institutes of health stroke scale(NIHSS)[J]. Journal of Physiotherapy, 2014, 60(1):61.
[6] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246-257.
[7] 高长玉,吴成翰,赵建国,等.中国脑梗死中西医结合诊治指南(2017)[J].中国中西医结合杂志,2018,38(2):136-144.
[8] Wardlaw JM, Murray V, Berge E, et al. Recombinant tissue plasminogen activator for acute ischaemic stroke:an updated systematic review and meta-analysis[J]. Lancet, 2012, 379(9834):2364-2372.
[9] Widlansky ME, Jensen DM, Wang Jing-li, et al. miR-29 contributes to normal endothelial function and can restore it in cardiometabolic disorders[J]. EMBO Molecular Medicine, 2018, 10(3):8046.
[10] Khanna S, Rink C, Ghoorkhanian R, et al. Loss of miR-29b following acute ischemic stroke contributes to neural cell death and infarct size[J]. Journal of Cerebral Blood Flow and Metabolism:Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 2013, 33(8):1197-1206.
[11] Chen Sheng-cai, Wang Meng-die, Yang Hang, et al. LncRNA TUG1 sponges microRNA-9 to promote neurons apoptosis by up-regulated Bcl2l11 under ischemia[J]. Biochemical and Biophysical Research Communications, 2017, 485(1):167-173.
[12] Tain YL. Hsu,CN.targeting on asymmetric Dimethylarginine-Related nitric Oxide-Reactive Oxygen species imbalance to reprogram the development of hypertension[J]. International Journal of Molecular Sciences, 2016, 17(12):e2020.
[13] Chung JW, Oh MJ, Cho YH, et al. Distinct roles of endothelial dysfunction and inflammation in intracranial atherosclerotic stroke[J]. European Neurology, 2017, 77(3/4):211-219.

更新日期/Last Update: 2019-06-25